Literature DB >> 35848036

Taste Impairments in a Parkinson's Disease Model Featuring Intranasal Rotenone Administration in Mice.

Dong Xu Yin1, Hiroki Toyoda1, Kazunori Nozaki2, Keitaro Satoh3, Ayano Katagiri1, Kazunori Adachi3, Takafumi Kato1, Hajime Sato1,3.   

Abstract

BACKGROUND: Taste impairments are often accompanied by olfactory impairments in the early stage of Parkinson's disease (PD). The development of animal models is required to elucidate the mechanisms underlying taste impairments in PD.
OBJECTIVE: This study was conducted to clarify whether the intranasal administration of rotenone causes taste impairments prior to motor deficits in mice.
METHODS: Rotenone was administrated to the right nose of mice once a day for 1 or 4 week(s). In the 1-week group, taste, olfactory, and motor function was assessed before and after a 1-week recovery period following the rotenone administration. Motor function was also continuously examined in the 4-weeks group from 0 to 5 weeks. After a behavioral test, the number of catecholamine neurons (CA-Nos) was counted in the regions responsible for taste, olfactory, and motor function.
RESULTS: taste and olfactory impairments were simultaneously observed without locomotor impairments in the 1-week group. The CA-Nos was significantly reduced in the olfactory bulb and nucleus of the solitary tract. In the 4-week group, locomotor impairments were observed from the third week, and a significant reduction in the CA-Nos was observed in the substantia nigra (SN) and ventral tegmental area (VTA) at the fifth week along with the weight loss.
CONCLUSION: The intranasal administration of rotenone caused chemosensory and motor impairments in an administration time-period dependent manner. Since chemosensory impairments were expressed prior to the locomotor impairments followed by SN/VTA CA neurons loss, this rotenone administration model may contribute to the clarification of the prodromal symptoms of PD.

Entities:  

Keywords:  Parkinson’s disease; catecholamines; experimental animal models; olfaction disorders; pesticides; rotenone; taste disorders

Mesh:

Substances:

Year:  2022        PMID: 35848036      PMCID: PMC9535587          DOI: 10.3233/JPD-223273

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.520


  64 in total

Review 1.  Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

Authors:  Heiko Braak; Kelly Del Tredici; Hansjürgen Bratzke; John Hamm-Clement; Daniele Sandmann-Keil; Udo Rüb
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

2.  Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

Authors:  Neil J Johnson; Leah R Hanson; William H Frey
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 3.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

4.  Intranasal Administration of Rotenone to Mice Induces Dopaminergic Neurite Degeneration of Dopaminergic Neurons in the Substantia Nigra.

Authors:  Hitoshi Sasajima; Sadaharu Miyazono; Tomohiro Noguchi; Makoto Kashiwayanagi
Journal:  Biol Pharm Bull       Date:  2017       Impact factor: 2.233

5.  Genetic control of oromotor phenotypes: A survey of licking and ingestive behaviors in highly diverse strains of mice.

Authors:  Steven J St John; Lu Lu; Robert W Williams; Jennifer Saputra; John D Boughter
Journal:  Physiol Behav       Date:  2017-04-12

6.  Taste function in early stage treated and untreated Parkinson's disease.

Authors:  Richard L Doty; Michael T Nsoesie; Inna Chung; Allen Osman; Ian Pawasarat; Julie Caulfield; Howard Hurtig; Jonathan Silas; Jacob Dubroff; John E Duda; Gui-Shuang Ying; Hakan Tekeli; Fidias E Leon-Sarmiento
Journal:  J Neurol       Date:  2014-12-06       Impact factor: 4.849

7.  Immunocytochemical organization and sour taste activation in the rostral nucleus of the solitary tract of mice.

Authors:  Jennifer M Stratford; John A Thompson; Thomas E Finger
Journal:  J Comp Neurol       Date:  2016-08-11       Impact factor: 3.215

8.  Phenylthiocarbamide (PTC) perception in Parkinson disease.

Authors:  Paul J Moberg; Catherine C Balderston; Jacqueline H Rick; David R Roalf; Daniel Weintraub; Galit Kleiner-Fisman; Matthew B Stern; John E Duda
Journal:  Cogn Behav Neurol       Date:  2007-09       Impact factor: 1.600

9.  Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease.

Authors:  Melissa Furlong; Caroline M Tanner; Samuel M Goldman; Grace S Bhudhikanok; Aaron Blair; Anabel Chade; Kathleen Comyns; Jane A Hoppin; Meike Kasten; Monica Korell; J William Langston; Connie Marras; Cheryl Meng; Marie Richards; G Webster Ross; David M Umbach; Dale P Sandler; Freya Kamel
Journal:  Environ Int       Date:  2014-11-21       Impact factor: 9.621

10.  Chemically Induced Models of Parkinson's Disease: History and Perspectives for the Involvement of Ferroptosis.

Authors:  Shuheng Wen; Toshihiko Aki; Kana Unuma; Koichi Uemura
Journal:  Front Cell Neurosci       Date:  2020-12-23       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.